Archivio

Invasive ventilation in children during COVID-19 pandemic

Family-centered care in the PICU during the COVID-19 pandemic

The end of the pandemic

A comparison of five paediatric dosing guidelines for antibiotics

The bat, the pangolin and the city: a tale of COVID-19

Interim pharmacokinetic analysis of a multi-centre randomised open label phase IIb study in neonates to validate the meta-analysis population pharmacokinetic model used to simulate an optimised dosing regimen in neonates and infants aged < 90 days: the NeoVanc trial

An optimised dosing regimen vs. a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in infants less than 90 days: the NeoVanc trial

Respiratory pathogens detected in children with community-acquired sepsis-like syndrome in 6 European countries

Aetiology and outcome of children hospitalised for acute respiratory tract infections in Europe: findings from a multi-country combined case-control and cohort study

Application of WISCA (Weighted Incidence Syndromic Combination Antibiogram) to guide empiric therapy in oncological paediatric patients with febrile neutropenia

Antibiotic treatment for paediatric outpatients with community-acquired pneumonia: findings from 10 years of prescribing habits in Italy

Ethics in PIC in the time of COVID

Prof. Sarah Walker leads the CIS study on COVID-19

Overview on COVID-19 outbreak

Tribute to Lynda Harper

RECOVER enrolls first patients in its COVID-19 studies!

The role of ECMO in the current pandemic – Experience so far

An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial